These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cellular electrophysiological effect of terikalant in the dog heart. Biliczki P, Acsai K, Virág L, Tálosi L, Jost N, Biliczki A, Papp JG, Varró A. Eur J Pharmacol; 2005 Mar 14; 510(3):161-6. PubMed ID: 15763239 [Abstract] [Full Text] [Related]
4. Inotropic and electrophysiological effects of AB--2, a new antiarrhythmic agent, on isolated cardiac preparations. Beresewicz A, Pytkowski B, Sedek G, Zdanowski K. Pol J Pharmacol Pharm; 1983 Mar 14; 35(3):223-32. PubMed ID: 6651921 [Abstract] [Full Text] [Related]
6. Voltage- and rate-dependent depression of Vmax of action potentials by a new antiarrhythmic agent, E-0747, in swine cardiac Purkinje fibers. Sawada K, Shoji T, Igarashi T, Hiraoka M. J Cardiovasc Pharmacol; 1987 Jan 14; 9(1):51-6. PubMed ID: 2434794 [Abstract] [Full Text] [Related]
7. In vivo and in vitro antiarrhythmic and arrhythmogenic effects of N-acetyl procainamide. Dangman KH, Hoffman BF. J Pharmacol Exp Ther; 1981 Jun 14; 217(3):851-62. PubMed ID: 6164783 [Abstract] [Full Text] [Related]
8. Time course of the electrophysiological effects of quinidine on canine cardiac Purkinje fibers: concentration dependence and comparison with lidocaine and disopyramide. Nattel S, Bailey JC. J Pharmacol Exp Ther; 1983 Apr 14; 225(1):176-80. PubMed ID: 6834270 [Abstract] [Full Text] [Related]
9. Barucainide, a novel class Ib antiarrhythmic agent with a slow kinetic property: electrophysiologic observations in isolated canine and rabbit cardiac muscle. Takanaka C, Singh BN. Am Heart J; 1990 May 14; 119(5):1050-60. PubMed ID: 2330863 [Abstract] [Full Text] [Related]